Paper19084813
Atrial-selective effects of chronic amiodarone in the management of atrial fibrillation.
Burashnikov A and 5 others. Heart Rhythm, 2008. Cited by 61 papers, by iCite.
Cite this record
ConductScience Library. Atrial-selective effects of chronic amiodarone in the management of atrial fibrillation. Papers, record 19084813. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19084813
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Comparative Study, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Amiodarone | Major topic |
| Anti-Arrhythmia Agents | Major topic |
| Atrial Fibrillation | Major topic |
| Heart Atria | Major topic |
| Administration, Oral | |
| Animals | |
| Atrial Function | |
| Disease Models, Animal | |
| Dogs | |
| Dose-Response Relationship, Drug | |
| Electrocardiography | |
| Follow-Up Studies | |
| Heart Rate | |
| Membrane Potentials | |
| Time Factors | |
| Treatment Outcome |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 HL047678 | NHLBI NIH HHS | United States | R01HL047678 | PubMed and NIH | NIH RePORTER |
| HL-47687 | NHLBI NIH HHS | United States | S15HL047687 | PubMed and NIH | NIH RePORTER |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 19084814 | Does the postrepolarization refractoriness play a role in amiodarone's antiarrhythmic efficacy? | https://conductscience.org/library/papers/19084814 |
Source PubMed
References31
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16556442 | Effects of amiodarone on electrical and structural remodeling induced in a canine rapid pacing-induced persistent atrial fibrillation model. | Eur J Pharmacol | 2006 | https://conductscience.org/library/papers/16556442 | PubMed |
| 2 | 9395170 | Chronic amiodarone reduces transmural dispersion of repolarization in the canine heart. | J Cardiovasc Electrophysiol | 1997 | https://conductscience.org/library/papers/9395170 | PubMed |
| 3 | 12695296 | Reinduction of atrial fibrillation immediately after termination of the arrhythmia is mediated by late phase 3 early afterdepolarization-induced triggered activity. | Circulation | 2003 | https://conductscience.org/library/papers/12695296 | PubMed |
| 4 | 7491312 | Basic concepts in cellular cardiac electrophysiology: Part II: Block of ion channels by antiarrhythmic drugs. | Pacing Clin Electrophysiol | 1995 | https://conductscience.org/library/papers/7491312 | PubMed |
| 5 | 7782268 | Acute effects of amiodarone on membrane properties, refractoriness, and conduction in guinea pig papillary muscles. | Heart Vessels | 1995 | https://conductscience.org/library/papers/7782268 | PubMed |
| 6 | 11343415 | Late sodium current is a novel target for amiodarone: studies in failing human myocardium. | J Mol Cell Cardiol | 2001 | https://conductscience.org/library/papers/11343415 | PubMed |
| 7 | 1282594 | Effects of WAY-123,398, a new class III antiarrhythmic agent, on cardiac refractoriness and ventricular fibrillation threshold in anesthetized dogs: a comparison with UK-68798, E-4031, and dl-sotalol. | J Cardiovasc Pharmacol | 1992 | https://conductscience.org/library/papers/1282594 | PubMed |
| 8 | 15302796 | Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties. | Circulation | 2004 | https://conductscience.org/library/papers/15302796 | PubMed |
| 9 | 17139288 | Innovative approaches to anti-arrhythmic drug therapy. | Nat Rev Drug Discov | 2006 | https://conductscience.org/library/papers/17139288 | PubMed |
| 10 | 18670368 | Atrial-selective sodium channel blockers: do they exist? | J Cardiovasc Pharmacol | 2008 | https://conductscience.org/library/papers/18670368 | PubMed |
| 11 | 3409504 | Mechanisms of depressed conduction from long-term amiodarone therapy in canine myocardium. | Circulation | 1988 | https://conductscience.org/library/papers/3409504 | PubMed |
| 12 | 15148061 | Transmembrane action potential heterogeneity in the canine isolated arterially perfused right atrium: effect of IKr and IKur/Ito block. | Am J Physiol Heart Circ Physiol | 2004 | https://conductscience.org/library/papers/15148061 | PubMed |
| 13 | 11973411 | Chronic and acute effects of dronedarone on the action potential of rabbit atrial muscle preparations: comparison with amiodarone. | J Cardiovasc Pharmacol | 2002 | https://conductscience.org/library/papers/11973411 | PubMed |
| 14 | 12649377 | Amiodarone-induced postrepolarization refractoriness suppresses induction of ventricular fibrillation. | J Pharmacol Exp Ther | 2003 | https://conductscience.org/library/papers/12649377 | PubMed |
| 15 | 10466495 | The M cell: its contribution to the ECG and to normal and abnormal electrical function of the heart. | J Cardiovasc Electrophysiol | 1999 | https://conductscience.org/library/papers/10466495 | PubMed |
| 16 | 17765636 | A practical guide for clinicians who treat patients with amiodarone: 2007. | Heart Rhythm | 2007 | https://conductscience.org/library/papers/17765636 | PubMed |
| 17 | 15243307 | In vivo and in vitro characterization of the novel antiarrhythmic agent SSR149744C: electrophysiological, anti-adrenergic, and anti-angiotensin II effects. | J Cardiovasc Pharmacol | 2004 | https://conductscience.org/library/papers/15243307 | PubMed |
| 18 | 14985067 | In vivo electrophysiological effects of a selective slow delayed-rectifier potassium channel blocker in anesthetized dogs: potential insights into class III actions. | Cardiovasc Res | 2004 | https://conductscience.org/library/papers/14985067 | PubMed |
| 19 | 3941203 | Acute and chronic effects of amiodarone on ventricular refractoriness, intraventricular conduction and ventricular tachycardia induction. | J Am Coll Cardiol | 1986 | https://conductscience.org/library/papers/3941203 | PubMed |
| 20 | 17785620 | Atrium-selective sodium channel block as a strategy for suppression of atrial fibrillation: differences in sodium channel inactivation between atria and ventricles and the role of ranolazine. | Circulation | 2007 | https://conductscience.org/library/papers/17785620 | PubMed |
Cited by43
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 61 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42631151 | Personalized in silico modeling of cardiac ion channel variants to predict drug-induced proarrhythmia risk. | Front Physiol | 2026 | https://conductscience.org/library/papers/42631151 | PubMed |
| 41944301 | Causal AI in Cardiac Arrhythmia: From Pattern Recognition to Mechanistic Insight. | Clin Cardiol | 2026 | https://conductscience.org/library/papers/41944301 | PubMed |
| 39739528 | The Value of P-Wave Parameters Changes in Predicting Catheter Ablation Outcomes for Paroxysmal Atrial Fibrillation. | Ann Noninvasive Electrocardiol | 2025 | https://conductscience.org/library/papers/39739528 | PubMed |
| 39330335 | The Role of P Wave Parameters in Predicting Pulmonary Vein Isolation Outcomes for Paroxysmal Atrial Fibrillation: An Observational Cohort Study. | J Cardiovasc Dev Dis | 2024 | https://conductscience.org/library/papers/39330335 | PubMed |
| 38619735 | Extracellular acidification reveals the antiarrhythmic properties of amiodarone related to late sodium current-induced atrial arrhythmia. | Pharmacol Rep | 2024 | https://conductscience.org/library/papers/38619735 | PubMed |
| 38146652 | Effect of Flecainide and Ibutilide Alone and in Combination to Terminate and Prevent Recurrence of Atrial Fibrillation. | Circ Arrhythm Electrophysiol | 2024 | https://conductscience.org/library/papers/38146652 | PubMed |
| 37656133 | Amiodarone prevents wave front-tail interactions in patients with heart failure: an in silico study. | Am J Physiol Heart Circ Physiol | 2023 | https://conductscience.org/library/papers/37656133 | PubMed |
| 36310729 | Widely split P waves in a patient with atrial enlargement and prior atrial flutter catheter ablations. | HeartRhythm Case Rep | 2022 | https://conductscience.org/library/papers/36310729 | PubMed |
| 33165131 | Investigational Anti-Atrial Fibrillation Pharmacology and Mechanisms by Which Antiarrhythmics Terminate the Arrhythmia: Where Are We in 2020? | J Cardiovasc Pharmacol | 2020 | https://conductscience.org/library/papers/33165131 | PubMed |
| 32470968 | Inhibitory Effects of Dronedarone on Small Conductance Calcium Activated Potassium Channels in Patients with Chronic Atrial Fibrillation: Comparison to Amiodarone. | Med Sci Monit | 2020 | https://conductscience.org/library/papers/32470968 | PubMed |
| 32453071 | The Small Conductance Calcium-Activated Potassium Channel Inhibitors NS8593 and UCL1684 Prevent the Development of Atrial Fibrillation Through Atrial-Selective Inhibition of Sodium Channel Activity. | J Cardiovasc Pharmacol | 2020 | https://conductscience.org/library/papers/32453071 | PubMed |
| 30306295 | German Cardiac Society Working Group on Cellular Electrophysiology state-of-the-art paper: impact of molecular mechanisms on clinical arrhythmia management. | Clin Res Cardiol | 2019 | https://conductscience.org/library/papers/30306295 | PubMed |
| 25604621 | Impact of hybrid procedure on P wave duration for atrial fibrillation ablation. | J Interv Card Electrophysiol | 2015 | https://conductscience.org/library/papers/25604621 | PubMed |
| 24999375 | Pulmonary Vein Sleeves as a Pharmacologic Model for the Study of Atrial Fibrillation. | Electrofisiol Arritm | 2010 | https://conductscience.org/library/papers/24999375 | PubMed |
| 24874201 | Ranolazine effectively suppresses atrial fibrillation in the setting of heart failure. | Circ Heart Fail | 2014 | https://conductscience.org/library/papers/24874201 | PubMed |
| 24738652 | Vernakalant for the conversion of atrial fibrillation: the new kid on the block? | Ann Noninvasive Electrocardiol | 2014 | https://conductscience.org/library/papers/24738652 | PubMed |
| 23637539 | Safety and efficacy of vernakalant for acute cardioversion of atrial fibrillation: an update. | Vasc Health Risk Manag | 2013 | https://conductscience.org/library/papers/23637539 | PubMed |
| 23588622 | Electrocardiographic P wave changes after thoracoscopic pulmonary vein isolation for atrial fibrillation. | J Interv Card Electrophysiol | 2013 | https://conductscience.org/library/papers/23588622 | PubMed |
| 23108433 | Role of late sodium channel current block in the management of atrial fibrillation. | Cardiovasc Drugs Ther | 2013 | https://conductscience.org/library/papers/23108433 | PubMed |
| 22370957 | Atrial-selective prolongation of refractory period with AVE0118 is due principally to inhibition of sodium channel activity. | J Cardiovasc Pharmacol | 2012 | https://conductscience.org/library/papers/22370957 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19084813
GET https://conductscience.org/api/papers/v1/19084813/references?page=2